Drug developer with kidney disease treatment raises $13M ahead of IND filing
Complexa, a drug developer using synthetic fatty acids to treat chronic and acute kidney disease, has raised $13 million in a Series B financing round, according to a company statement. The new funding comes as it prepares to file an IND for an oral formulation for chronic kidney disease and will help advance its Phase […]